Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Chongqing Lummy Seeks to Buy Remaining 40% of Sichuan Hygien

publication date: Jul 19, 2013
Chongqing Lummy Pharmaceutical Co. revealed it will bid for the 40% stake in Sichuan Hygien Pharma held by Chongqing Venture Capital Co., Ltd. The bid will be at least 44 million RMB ($7 million). If it is successful, Chongqing Lummy will own all of Sichuan Hygien. In 2010, it paid 54 million RMB ($9 million) for its initial 60% stake in Sichuan Hygien. More details....

Stock Symbol: (SHE: 300006)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital